India exports 50 million hydroxychloroquine tablets to U.S. for COVID-19 fight: source
India has shipped 50 million tablets of hydroxychloroquine to the United States, an Indian source with direct knowledge of the exports said, although U.S. regulators warned the anti-malarial drug may have harmful side effects in the treatment of COVID-19.
